Bnp Paribas Asset Management Holding S.A. Cytokinetics Inc Transaction History

Bnp Paribas Asset Management Holding S.A.

$37.3 Billion
Q1 2025

A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Cytokinetics Inc stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 522,468 shares of CYTK stock, worth $17.1 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

522,468

Previous 489,362 6.77%

Holding current value

$17.1 Million

Previous $23 Million 8.79%

% of portfolio

0.06%

Previous 0.06%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$40.19 - $51.12 $1.33 Million - $1.69 Million	33,106 Added 6.77%	522,468 $21 Million
Q4 2024 Feb 11, 2025	BUY	$46.36 - $58.62 $7.48 Million - $9.45 Million	161,290 Added 49.16%	489,362 $23 Million
Q3 2024 Nov 08, 2024	SELL	$51.22 - $60.16 $2.87 Million - $3.37 Million	-55,970 Reduced 14.57%	328,072 $17.3 Million
Q2 2024 Jul 29, 2024	BUY	$47.86 - $75.05 $1.41 Million - $2.22 Million	29,544 Added 8.33%	384,042 $20.8 Million
Q1 2024 May 08, 2024	SELL	$63.75 - $108.06 $7.18 Million - $12.2 Million	-112,580 Reduced 24.1%	354,498 $24.9 Million
Q4 2023 Feb 09, 2024	SELL	$26.88 - $83.49 $4.02 Million - $12.5 Million	-149,400 Reduced 24.23%	467,078 $39 Million
Q3 2023 Nov 13, 2023	BUY	$29.46 - $36.61 $5.52 Million - $6.86 Million	187,259 Added 43.63%	616,478 $18.2 Million
Q2 2023 Aug 08, 2023	SELL	$32.62 - $40.75 $4.42 Million - $5.52 Million	-135,533 Reduced 24.0%	429,219 $14 Million
Q1 2023 May 08, 2023	SELL	$33.36 - $45.71 $1.16 Million - $1.59 Million	-34,790 Reduced 5.8%	564,752 $19.9 Million
Q4 2022 Feb 09, 2023	SELL	$35.77 - $51.11 $1.05 Million - $1.5 Million	-29,257 Reduced 4.65%	599,542 $27.5 Million
Q3 2022 Nov 10, 2022	SELL	$38.54 - $54.52 $952,477 - $1.35 Million	-24,714 Reduced 3.78%	628,799 $30.5 Million
Q2 2022 Aug 04, 2022	SELL	$33.93 - $48.92 $4.74 Million - $6.83 Million	-139,643 Reduced 17.61%	653,513 $25.7 Million
Q1 2022 May 12, 2022	SELL	$29.74 - $46.0 $1.41 Million - $2.18 Million	-47,445 Reduced 5.64%	793,156 $29.2 Million
Q4 2021 Feb 09, 2022	BUY	$34.35 - $46.38 $647,634 - $874,448	18,854 Added 2.29%	840,601 $38.3 Million
Q3 2021 Nov 08, 2021	SELL	$18.54 - $35.74 $5.08 Million - $9.79 Million	-274,057 Reduced 25.01%	821,747 $29.4 Million
Q2 2021 Aug 05, 2021	BUY	$19.79 - $26.99 $3.74 Million - $5.1 Million	189,082 Added 20.85%	1,095,804 $21.7 Million
Q1 2021 May 05, 2021	BUY	$18.57 - $25.68 $5.04 Million - $6.98 Million	271,636 Added 42.77%	906,722 $21.1 Million
Q4 2020 Feb 12, 2021	BUY	$15.26 - $28.61 $9.69 Million - $18.2 Million	635,086 New	635,086 $13.2 Million

Others Institutions Holding CYTK

# of Institutions

408

Shares Held

127M

Call Options Held

3.66M

Put Options Held

900K

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $3.08B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bnp Paribas Asset Management Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Bnp Paribas Asset Management Holding S.A. with notifications on news.

Account

Bnp Paribas Asset Management Holding S.A. Cytokinetics Inc Transaction History